Fatty liver, hepatitis and alcohol-related liver findings compared

An abnormal liver result can mean very different things, and an underwriter's first job is to work out which one. A fatty liver found on an ultrasound, a hepatitis C history that was treated, and liver enzymes raised by heavy drinking are three separate stories, with different causes, different tests that matter and different ways of changing over time. Putting them under one heading of "liver problem" is the quickest way to misjudge what an application will meet.

This post compares the three families side by side: infection, fat accumulation and alcohol-related injury. It explains what a reviewer is trying to learn from each, what the blood tests and imaging can and cannot show, and which records tend to move the decision. It is general information, not medical advice. Insurers differ, and nobody outside the underwriting department can predict a particular offer.

What the liver tests measure, and what they do not

Most people first hear about a liver issue because of a routine blood panel. The common items, which also appear in the labs collected for a what a life insurance blood and urine test looks for, are:

• ALT and AST. Enzymes released when liver cells are irritated or damaged. Raised values say that something is irritating the liver. They do not say what. ALT tends to be more specific to the liver, while AST is also found in muscle, so a hard workout before a test can nudge AST.
• GGT and alkaline phosphatase. Enzymes that reflect the bile ducts and are often raised with alcohol use or certain medications. GGT in particular is read alongside what you say about drinking.
• Bilirubin, albumin and clotting measures. These speak to how well the liver is doing its job, not just whether it is irritated. A liver can have mildly raised enzymes and still work normally, while a scarred liver can show normal enzymes and poor function.
• Platelet count. A falling platelet count can be a clue to advanced scarring, which is why it appears in some screening formulas.

Imaging and special tests add a second layer. An ultrasound can show that the liver looks bright, which suggests fat. Elastography, a scan that measures how stiff the liver is, estimates scarring without a needle. Blood-based scores combine routine values with age to estimate the likelihood of scarring. A biopsy, a small tissue sample, is less often needed now but remains the most direct look.

The concept that matters for underwriting is the sequence from irritation to scarring. Liver injury of any cause can move from inflammation to fibrosis, which is scarring, and at the far end to cirrhosis, where scarring is widespread and the liver's structure and function change. Underwriters care more about where someone is on that sequence, and which way the trend is moving, than about which cause started it.

The three families at a glance

The table is a map of how the questions differ, not a set of outcomes.

Viral hepatitis: infection first, scarring second

For hepatitis C, the central questions are whether the virus has been cleared and how much scarring occurred. Modern treatment can cure the infection, and cure is documented by a blood test showing no detectable virus some weeks after treatment ends, called a sustained virologic response. The existing guide Life insurance with hepatitis C goes into the cure rate and the CDC's figures, so this post does not repeat them. In underwriting terms, a documented cure with little or no scarring is a very different file from active infection or cirrhosis. The file normally includes the treatment dates, the proof-of-cure result and some measure of liver stiffness or scarring.

Hepatitis B is a separate virus and works differently. Many people carry a record of hepatitis B in their charts for one of three reasons: they were vaccinated, they were exposed and cleared the infection, or they have a chronic infection. Those three lines on a lab report look similar to a layperson and are very different to a reviewer. If you have chronic hepatitis B, underwriters usually ask about viral load, enzyme levels, whether you take medication and what monitoring shows. The records that matter are the specialist's notes and the latest lab trend.

Hepatitis A is usually an acute, short illness that resolves, and a past episode is generally a minor historical item once recovery is documented. Anyone with a hepatitis history should find out from their doctor which type the chart refers to, because the application questions often ask about each separately.

What improves a viral file: documentation, time since cure or stability, a specialist's summary that states the degree of scarring, and an absence of complicating factors such as heavy alcohol use or other substance history. What complicates it: cirrhosis, active infection that has not been treated, a history of liver cancer screening with abnormal findings, or coinfection. See life insurance in recovery from substance use where drug use is part of the story.

Fatty liver: common, quiet and tied to the rest of the file

Fatty liver is the name for fat accumulating in the liver. Medical groups have revised the terms over the years; you may see "NAFLD," "NASH" or the newer "MASLD" and "MASH" in a chart. For an applicant, the key idea is that these labels describe a spectrum, from simple fat without much inflammation, to fat with inflammation, to fat with scarring.

It is often discovered by accident. A scan done for abdominal pain, a gallbladder check, or a mildly raised ALT on a routine panel leads to an ultrasound that says "increased echogenicity" or "hepatic steatosis." That finding alone is not a diagnosis of liver damage. It says there is fat.

What an underwriter looks for:

1. Is there inflammation or scarring? Elastography, a blood-based fibrosis score or a specialist note usually answers this. Fat with no scarring is generally treated more favorably than fat with fibrosis.
2. Is the enzyme trend normal, improving or rising? A single raised ALT is less informative than a series over time.
3. What else is going on? Fatty liver clusters with extra weight, prediabetes or diabetes, high triglycerides and high blood pressure. The underwriter will price the file as a whole. See life insurance, weight and build charts, life insurance with type 1 or type 2 diabetes and life insurance with high cholesterol.
4. What is the plan? A documented effort, such as weight loss or improved blood sugar, with enzymes responding, makes the picture more hopeful. Some people with fatty liver also take weight-loss medication, which has its own underwriting notes (see the GLP-1 guide).
5. Alcohol. Because alcohol also causes fat in the liver, the form asks how much you drink. An inaccurate answer here conflicts with exam labs.

Because it is so closely linked to the other items in a metabolic profile, a fatty liver finding is often less decisive on its own than the underlying weight, glucose and blood pressure picture. Improving those items can improve the whole file, which is why many applicants are better served by a documented trend than by a single snapshot.

Alcohol-related findings: the answers and the labs are read together

Alcohol-related liver findings usually reach an underwriter in one of two ways: a lab result such as a raised GGT or AST-to-ALT pattern that suggests alcohol, or a history in your records, such as a diagnosis, counseling or treatment.

The reviewer's questions are:

• How much and how long? Applications ask about current and past drinking. Answers are compared with the labs and with any medical notes. Understating alcohol use is a common cause of trouble. See how underwriters ask about alcohol and what the answers signal for how the questions are framed.
• What has the liver shown? Enzymes, imaging, and whether there is scarring. Alcohol-related inflammation can settle when drinking stops, and enzymes may normalize over months, while scarring may not fully reverse.
• What changed and when? For someone who has reduced or stopped drinking, the time since the change and any treatment or support, and whether there were relapses, are central. life insurance in recovery from substance use and life insurance in recovery from substance use, stage by stage describe how time and documentation are read.
• Related events. Insurers also ask about alcohol-related driving offenses and hospital stays.
• Complications. Fluid in the abdomen, bleeding from enlarged veins, confusion linked to liver failure, or a transplant evaluation are major factors and typically lead to a decline for standard coverage.

An important difference from the other two families: the story here depends partly on behavior that the applicant is asked to describe. That makes honest, consistent answers especially valuable. The labs often reveal more than the form says, and an inconsistency tends to be weighed more heavily than the fact of the drinking itself.

What the follow-up records need to show

The records an underwriter asks for are not identical across the three, but they overlap. A useful way to prepare is to gather these in advance.

For any liver finding

• The dates and values of your liver enzyme tests over the past few years, ideally in one list.
• Imaging reports, with the wording of the radiologist's conclusion.
• Notes from the specialist, such as a gastroenterologist or hepatologist, if you have seen one.
• A list of every medication, including supplements, since some drugs and herbal products can affect the liver.

For viral hepatitis

• The type of hepatitis and the date of diagnosis.
• Treatment dates and the result of the post-treatment test for hepatitis C, or the monitoring record for hepatitis B.
• The most recent measure of scarring.

For fatty liver

• Weight and waist trend if your doctor has recorded it, A1c or glucose results and lipid results.
• Any elastography or fibrosis score, and the plan your doctor has given you.

For alcohol-related findings

• A clear timeline of changes in drinking, any counseling or treatment dates and the latest lab trend.
• A specialist note on whether there is scarring.

Underwriters usually request an attending physician statement from the treating doctor to confirm these. Requests can take weeks, which is a good reason to start gathering early. attending physician statements and why they slow an application explains why they are slow and what you can do.

How the outcomes tend to differ

Without promising anything, the pattern of outcomes in practice runs along the same axes in all three families.

• Normal or near-normal liver function, no scarring, a stable trend. The condition may be a small factor in the decision, or sometimes none, and the rest of the file such as build, blood pressure and tobacco use does more of the work.
• Mild abnormalities or a short history. A postponement may be offered while follow-up tests are completed. postponed application: why insurers make you wait explains what that means.
• Moderate findings. A rated offer, meaning a higher premium through a table rating or flat extra, is a common result. table ratings and flat extras explained explains the mechanics.
• Advanced scarring or complications. A decline for traditional coverage is more likely, and smaller guaranteed products may be the realistic option. See Declined for life insurance? What to do next.

Insurers do not use identical rules, so the same liver history can get different answers at different companies. An independent agent who knows how each insurer handles liver findings can steer an informal inquiry before you apply. informal inquiries: testing an insurer's view before you apply covers how that works.

Three illustrative applicants

These are invented for the example and are not predictions.

Applicant 1 was treated for hepatitis C three years ago. The post-treatment test showed no virus, and an elastography scan showed little scarring. The file includes the treatment record, the proof-of-cure result and the specialist's note. The reviewer's questions are mostly answered by documents. The outcome may depend on how that insurer treats a cured infection and on whether any alcohol or drug history appears.

Applicant 2 has fatty liver found on an ultrasound, a mildly raised ALT that has come down over two years as the applicant lost weight, normal blood sugar and no scarring on the scan. The reviewer will weigh the improving trend, the build and the lipids. The finding may matter less than the weight and metabolic numbers around it.

Applicant 3 has raised GGT and AST on exam labs and wrote "occasionally" for alcohol use. The enzymes suggest more. The underwriter requests records and may find a note from a doctor about weekly drinking. The inconsistency, not just the number, shapes the decision and may delay it. A clear and accurate answer from the start would have saved weeks.

The three applicants show the point of the comparison: the same words, "abnormal liver tests," lead to different questions, and the most helpful preparation is different for each.

Key takeaways

• Underwriters ask what caused the liver finding and how far along the path from inflammation to scarring it has gone, not just whether a test was abnormal.
• Viral hepatitis files turn on cure or control and on scarring. Fatty liver files turn on scarring and on the weight, glucose and blood pressure around it. Alcohol-related files turn on the pattern of drinking, the labs and the time since any change.
• A trend in enzymes over time carries more weight than a single reading, and a specialist's note on scarring is often the most useful document you can supply.
• Answers about alcohol are checked against GGT and other labs, so accuracy matters more than the amount.
• Gather your records and ask an agent about an informal inquiry before a formal application, since insurers differ on liver histories.